11939

Epidermolizis Bülloza

Bu derleme çalışmasında, epidermolizis bülloza literatür incelemesi ile gözden geçirildi. Epidermolizis bülloza tıp ve d ş hek mler n n dah l olduğu multidisipliner tedavi yaklaşımlarının gerektiği bir problemdir. Diş hekimleri ve epidermolizis bülloza vakaları oral hijyenin ve dental stabilitenin sağlanmasının öneminin bilincinde olmalıdır. Epidermolizis büllozanın diş hekimleri tarafından daha iyi anlaşılmalı bunun için ilgili araştırma ve yayınların devam etmesinin gerektiği düşünüldü, böylece diş hekimi ve tıp hekimleri arasında farkındalık oluşturabileceği düşünüldü.

Anahtar Kelimeler:

Epidermolizis bülloza, diş hekimliği, genetik.

Epidermolysis Bullosa

In this review study, epidermolysis bullosa was deal with a literature review. Epidermolysis bullosa is a problem that requires multidisciplinary treatment approaches including medicine and dentists. Dentists and epidermolysis bullosa cases should be a ware of the importance of oral hygiene and dental stability. It was thought that epidermolysis bullosa should be better understood by dentists and that related research hand publications should be continued, so that awareness among dentists and medical doctors could be improved.

Keywords:

Epidermolysisbullosa, dentistry, genetics. Epidermolysisbullosa, dentistry, genetics.,

PDF

___

1. Karaduman A. Kalitsal Büllü Hastaliklar/Inherited Bullous Diseases. Turkderm. 2011;45:81.
2. Fine J-D. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5(1):12.
3. Wright JT, Fine JD, Johnson L. Dental caries risk in hereditary epidermolysis bullosa. Pediatr Dent. 1994;16:427.
4. Kulalı F, Özbakır H, Kundak S, Kalkanlı OH, Eriş D, Çolak R, vd. Epidermolizis Bülloza: Olgu Serisi. Jinekoloji Obstet ve Neonatoloji Tıp Derg. 2019;16(2):69–73.
5. Mariath LM, Santin JT, Schuler-Faccini L, Kiszewski AE. Inherited epidermolysis bullosa: update on the clinical and genetic aspects: Inherited epidermolysis bullosa. An Bras Dermatol 2020;95(5):551–69.
6. Limmer AL, Nwannunu CE, Shah R, Coleman K, Patel RR, Mui UN, vd. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review. Skin therapy letter.2019;24(3):7–9.
7. Laimer M, Prodinger C, Bauer JW. Hereditäre Epidermolysen. JDDG -Journal of the German Society of Dermatology. Wiley-VCH Verlag; 2015;13(11):1125–33.
8. Chiaverini C, Bourrat E, Mazereeuw-Hautier J, Hadj-Rabia S, Bodemer C, Lacour JP. Épidermolyses bulleuses héréditaires : protocole national de diagnostic et de soins (PNDS). Annales de Dermatologie et de Venereologie. 2017;144(1):6–35.
9. Fine J-D, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, vd. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.
10. Bruckner-Tuderman L. Newer treatment modalities in epidermolysis bullosa. Indian Dermatol Online J. 2019;10(3):244.
11. Al-Abadi A, Al-Azri SA, Bakathir A, Al-Riyami Y. Dental and anaesthetic challenges in a patient with dystrophic epidermolysis bullosa. Sultan Qaboos Univ Med Journal. 2016;16(4):e495–9.
12. Koyuncu O, Hakimoğlu S, Özkan M, Gökçe R, Akkurt Ç, Turhanoğlu S. Epidermolizis Bülloza Distrofikalı Hastada Anestezi Yönetimi. Mustafa Kemal Üniversitesi Tıp Derg. 2016;7 27 .
13. Marinkovich MP, Tang JY. Gene Therapy for Epidermolysis Bullosa. Journal of Investigative Dermatology. 2019;139(6):1221–6.
14. Yousef H, Sharma S. Anatomy, Skin (Integument), Epidermis. StatPearls. 2018.
15. ALTUNTAŞ M. Deri ve Yumuşak Doku Enfeksiyonları. Klin Tıp Aile Hekim. 11(1).
16. Sotiropoulou PA, Blanpain C. Development and homeostasis of the skin epidermis. Cold Spring Harb Perspect Biol. 2012;4(7).
17. Karabulut AA. Yenidoğanda Deri Fizyolojisi ve Topikal İlaç Kullanımı. Arch Turkish Dermatology Venerol. 2011;45.
18. Anatomy of the Skin and the Pathogenesis of Nonmelanoma Skin CancerClinicalKey. Facial plastic Surgery Clinics. 2017;25(3):283-289
19. Gonzales KAU, Fuchs E. Skin and Its Regenerative Powers: An Alliance between Stem Cells and Their Niche.Developmental Cell. Cell Press; 2017;43(4):387–401.
20. Schlessinger DI, Goyal A, Syed SYB, Sonthalia S. Embryology, epidermis. Içinde: StatPearls. 2020.
21. Parrish AR. The impact of aging on epithelial barriers.Tissue Barriers. Taylor and Francis Inc.; 2017;5(4).
22. Brandner JM. Importance of Tight Junctions in Relation to Skin Barrier Function. Curr Probl Dermatology. 2016;49:27–37.
23. Frank JA. Claudins and alveolar epithelial barrier function in the lung.Annals of the New York Academy of Sciences. Blackwell Publishing Inc.; 2012;175–83.
24. Hausmann R, Grepl M, Knecht V, Moeller MJ. The glomerular filtration barrier function: New concepts. Current Opinion in Nephrology and Hypertension. 2012;21(4):441–9.
25. Szaszi K, Amoozadeh Y. New insights into functions, regulation, and pathological roles of tight junctions in kidney tubular epithelium. International Review of Cell and Molecular Biology. 2014;205–71.
26. Castoldi A, Favero de Aguiar C, Moraes-Vieira P, Olsen Saraiva Câmara N. They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa. Curr Protein Pept Sci. 2015;16(7):655–71.
27. Sakisaka T, Takai Y. Biology and pathology of nectins and nectin-like molecules. Curr Opin Cell Biol. 2004;16(5):513–21.
28. Takai Y, Nakanishi H. Nectin and afadin: novel organizers of intercellular junctions. J Cell Sci. 2003;116(1):17–27.
29. Ikeda W, Nakanishi H, Miyoshi J, Mandai K, Ishizaki H, Tanaka M, vd. Afadina key molecule essential for structural organization of cell–cell junctions of polarized epithelia during embryogenesis. J Cell Biol. 1999;146(5):1117–32.
30. Akkuş D, Sönmez Mf. Hücre Adezyon Molekülü: Nektin. Sağlık Bilim Derg. 2012;21(3):205–11.
31. Fine JD. Inherited epidermolysis bullosa: Past, present, and future. Annals of the New York Academy of Sciences. 2010;1195(1):213–22.
32. Has C, Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes. C. 28, Experimental Dermatology. Blackwell Publishing Ltd; 2019;28(10):1146–52.
33. Sánchez-Jimeno C, Escámez MJ, Ayuso C, Trujillo-Tiebas MJ, del Río M. Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group. Actas Dermosifiliogr. 2018;109(2):104–22.
34. Nava EP, De La E, Ángeles T, Durán A, Ii G. Stomatologic management of dental malocclusion in patients with dystrophic epidermolysis bullosa using an interceptive guide of occlusion (IGO): Comparison of two cases Chief of the Pediatric Stomatology Department. II Attending Teacher in the Pediatric Stomatology Department. C. 2, Revista Mexicana de Ortodoncia. Medigraphic; 2014;2(2):114-121
35. Bolling MC, Lemmink HH, Jansen GHL, Jonkman MF. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol. 2011;164(3):637-644
36. Wally V, Hovnanian A, Ly J, Buckova H, Brunner V, Lettner T, vd. Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial. J Am Acad Dermatol. 2018;78(5):892-901.
37. Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R, vd. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol. 2012;67(5):904–17.
38. Krämer SM, Serrano MC, Zillmann G, Gálvez P, Araya I, Yanine N, vd. Oral Health Care for Patients with Epidermolysis Bullosa‐Best Clinical Practice Guidelines. Int J Paediatr Dent. 2012;22:1–35.
39. Bruckner-Tuderman L. Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features. Dermatologic Clinics. Dermatol Clin; 2010;28(1):107–14.
40. Horn HM, Tidman MJ. The clinical spectrum of dystrophic epidermolysis bullosa. Br J Dermatol. 2002;146(2):267–74.
41. El Hachem M, Diociaiuti A, Proto V, Fortugno P, Zambruno G, Castiglia D, vd. Kindler syndrome with severe mucosal involvement in a large Palestinian pedigree. Eur J Dermatol. 2015;25(1):14–9.
42. Has C, Castiglia D, del Rio M, Garcia Diez M, Piccinni E, Kiritsi D, vd. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum Mutat. 2011;32(11):1204–12.
43. Figueira EC, Murrell DF, Coroneo MT. Ophthalmic Involvement in Inherited Epidermolysis Bullosa. C. 28, Dermatologic Clinics. Dermatol Clin; 2010;28(1):143–52
44. Chan SMH, Dillon MJ, Duffy PG, Atherton DJ. Nephro-urological complications of epidermolysis bullosa in paediatric patients. Br J Dermatol. 2007;156(1):143–7.
45. Tammaro F, Calabrese R, Aceto G, Lospalluti L, Garofalo L, Bonifazi E, vd. End-stage renal disease secondary to IgA nephropathy in recessive dystrophic epidermolysis bullosa: A case report. Pediatr Nephrol. Ocak 2008;23(1):141–4.
46. Fewtrell MS, Allgrove J, Gordon I, Brain C, Atherton D, Harper J, vd. Bone mineralization in children with epidermolysis bullosa. Br J Dermatol. 2006;154(5):959–62.
47. Fine JD, Hall M, Weiner M, Li KP, Suchindran C. The risk of cardiomyopathy in inherited epidermolysis bullosa. Br J Dermatol. 2008;159(3):677–82.
48. Kudva P, Jain R. Periodontal manifestation of epidermolysis bullosa: Looking through the lens. J Indian Soc Periodontol. 2016;20(1):72–4.
49. Chrcanovic BR, Gomez RS. Dental implants in patients with epidermolysis bullosa: a systematic review. Oral and Maxillofacial Surgery. Springer Verlag; 2019;389–94.
50. Feijoo JF, Bugallo J, Limeres J, Peñarrocha D, Peñarrocha M, Diz P. Inherited epidermolysis bullosa: an update and suggested dental care considerations. J Am Dent Assoc. 2011;142(9):1017–25.
51. Wright JT, Fine JD, Johnson LB. Oral soft tissues in hereditary epidermolysis bullosa. Oral Surgery, Oral Med Oral Pathol. 1991;71(4):440–6.
52. André C-V, Bosc R, Chader H, Lange F, Hermeziu O, Meningaud J-P. [Low level laser therapy in inflammatory and infectious oral diseases]. Rev Stomatol Chir Maxillofac Chir Orale. 2014;115(1):22–7.
53. Sindici E, Astesano S, Fazio L, Dragonetti A, Pugliese M, Scully C, vd. Treatment of oral lesions in dystrophic epidermolysis bullosa: A case series of cord blood platelet gel and low-level laser therapy. Acta Dermato-Venereologica. Medical Journals/Acta. 2017;97(3):383–4.
54. Sindici E, Basiglio L, Cafaro A, Fazio L, Dragonetti A, Pugliese M, vd. The photobiomodulation therapy together with the use of cord blood platelet gel could be safely suggested as primary treatment for oral lesions in patients with inherited epidermolysis bullosa. Photodermatol Photoimmunol Photomed. 2020;36(4):318-321
55. Crawford EG, Burkes EJ, Briggaman RA. Hereditary epidermolysis bullosa: Oral manifestations and dental therapy. Oral Surgery, Oral Med Oral Pathol. 1976;42(4):490–500.
56. ÇAKA SY, TOPAL S, Altınkaynak AS. Anne sütü ile beslenmede karşılaşılan sorunlar. Turkiye Klin J Pediatr Nurs-Special Top. 2017;3:20–8
57. Hooda A, Rathee M, Yadav SPS, Gulia JS. Ankyloglossia: a review of current status. Internet J Otorhinolaryngol. 2010;12(2):1–7.
58. Özen MA, Eroğlu E. Yenidoğan dil frenulumunda güvenli ve etkili bir teknik: Frenotomi. Çoc. Cer. Derg. 2019;33 3 :126-129.
59. Johnson P. Tongue tie: exploding the myths. Infant. 2006;2(3):96–9.
60. Segal LM, Stephenson R, Dawes M, Feldman P. Prevalence, diagnosis, and treatment of ankyloglossia: methodologic review. Can Fam Physician. 2007;53(6):1027–33.
61. Lalakea ML, Messner AH. Ankyloglossia: does it matter? Pediatr Clin. 2003;50(2):381–97.
62. Didem Yalçın E. Sklerodermalı Hastaların Panoramik Görüntülerinde Kemik Bulguları ve Radyomorfometrik Indekslerin Değerlendirilmesi. 2015.
63. Melvin OG, Hunt KM, Jacobson ES. Hyaluronidase Treatment of Scleroderma-Induced Microstomia. JAMA Dermatology. American Medical Association; 2019 ;155(7):857–9.
64. Görkem S, Yılmaz AC, Tuncalı D, Terzioğlu A, Aslan G. Mikrostomide Converse-Kazanjian Komisüroplastisi: Erken Ve Geç Dönem Sonuçlarının Karşılaştırılması. Türk Plast Rekonstrüktif ve Estet Cerrahi Derg (Turk J Plast Surg). 2004;12(1).
65. Rana RE, Puri VA, Thakkur RK, Baliarsing AS. Median cleft of mandible and lower lip with ankyloglossia and ectopic minor salivary gland on tongue. Indian J Plast Surg. 2004;37(01):67–70.
66. Hunter ML, Roberts GJ. Oral and dental anomalies in Ellis van Creveld syndrome (chondroectodermal dysplasia): report of a case. Int J Paediatr Dent. 1998;8(2):153.
67. Krishan K, Garg A, Kanchan T, Machado M, Rao A. Enamel hypoplasia and its role in identification of individuals: A review of literature. Indian J Dent.. 2015;6(2):99.
68. Buschmann MM. Laminin-332-Mediated Proliferation Control: Mechanisms Regulating Formation of the Epithelium. University of Cincinnati; 2010.
69. Yuen WY, Pasmooij AMG, Stellingsma C, Jonkman MF. Enamel defects in carriers of a novel LAMA3 mutation underlying epidermolysis bullosa. Acta Dermato-Venereologica. Acta Derm Venereol. 2012;92(6):695–6.
70. Krämer SM. Oral care and dental management for patients with epidermolysis bullosa. Dermatologic Clinics. 2010;28(2):303–9.
71. Koçanalı B, Ak AT, Çoğulu D. Çocuklarda diş çürüğüne neden olan faktörlerin incelenmesi. Pediatr Res. 2014;1 2 :76–9.
72. Doğan BG, Gökalp S. Türkiye’de diş çürüğü durumu ve tedavi gereksinimi 2004. Hacettepe Diş Hekim Fakültesi Derg. 2008;32 2 :45–7.
73. Craig GG, Powell KR, Cooper MH. Caries progression in primary molars: 24‐month results from a minimal treatment programme. Community Dent Oral Epidemiol. 1981;9(6):260–5.
74. Cate JM ten. Current concepts on the theories of the mechanism of action of fluoride. Acta Odontol Scand. 1999;57(6):325–9.
75. Featherstone JD, Domejean-Orliaguet S, Jenson L, Wolff M, Young DA. Caries risk assessment in practice for age 6 through adult. CDA. 2007;35(10):703.
76. Fine J-D, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367–84.
77. Ayrancı Ü. Bir grup ilkokul öğrencisinde diş çürüğü saptama araştırması. Sürekli Tıp Eğitimi Derg. 2005;14 3 :50–4.
78. Marsh PD, Zaura E. Dental biofilm: ecological interactions in health and disease. J Clin Periodontol. 2017;44:12–22. 79. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78(922):455–9.
80. O’Donnell LE, Millhouse E, Sherry L, Kean R, Malcolm J, Nile CJ, vd. Polymicrobial Candida biofilms: friends and foe in the oral cavity. FEMS yeast research. FEMS Yeast Res; 2015;15(7).
81. Diaz PI, Xie Z, Sobue T, Thompson A, Biyikoglu B, Ricker A, vd. Synergistic interaction between candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect Immun. 2012;80(2):620–32.
82. Koo H, Andes DR, Krysan DJ. Candida–streptococcal interactions in biofilm-associated oral diseases. PLoS Pathogens. Public Library of Science; 2018;14(12).
83. Sharma P, Saxena S, Aggarwal P. Trends in the epidemiology of oral squamous cell carcinoma in Western UP: An institutional study. Indian J Dent Res. 2010;21(3):316–9.
84. Halboub ES, Abdulhuq M, Al-Mandili A. Oral and pharyngeal cancers in Yemen: a retrospective study. East Mediterr Heal J. 2012;18(9):985–91.
85. Marocchio LS, Lima J, Sperandio FF, Corrêa L, de Sousa SOM. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci. 2010;52(2):267–73.
86. Wanebo HJ, Blackinton D, Kouttab N, Mehta S. Contribution of serum inhibitory factors and immune cellular defects to the depressed cellmediated immunity in patients with head and neck cancer. Am J Surg. 1993;166(4):389–94.
87. Bulut E, Yılmaz F, Bekçioğlu B, Günhan Ö. Posterior Alveoler Krette Dişeti Yerleşimli Skuamoz Hücreli Karsinoma: Olgu Sunumu. Atatürk Üniversitesi Diş Hekim Fakültesi Derg. 2013;23 2 :239–43.